1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GILEAD SCIENCES, INC.
Gilead Sciences, Inc. XNAS: GILD

Gilead Sciences Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Soval...

Read More
135.93 4.79 (3.65%)
New 52W High today
13.2M
XNAS Volume
High volume today

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Affordable Valuation
57.7 / 100
Momentum Score
Technically Moderately Bullish
66.6 / 100
Turnaround Potential These stocks have average financials with good valuations and momentum, indicating turnaround potential View Similar Embed DVM
Analyst Price Target
135
1Yr Price target downside is -1%
26 analysts

23

S

5

W

3

O

2

T

SWOT Analysis

Gilead Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..